Literature DB >> 2912959

Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications.

G S Montana1, W C Fowler.   

Abstract

From April 1969 through December 1980, 527 patients with epidermoid carcinoma of the cervix received radical radiation therapy at North Carolina Memorial Hospital (NCMH). The treatment was designed to deliver a combined dose (external beam plus intracavitary) of 7000-8000 cGy to Point A and 5000-6500 cGy to the pelvic lymph nodes depending upon the stage of the disease. The maximum dose to the bladder and to the rectum were calculated from the orthogonal intracavitary placement films with contrast material in these organs. Thirty-three cases of cystitis and fifty-eight cases of proctitis were recorded. The mean bladder dose for the group of patients with cystitis was higher, 6661 +/- 1309 cGy, than that for the patients without cystitis, 6298 +/- 1305 cGy, p = .19. The risk of cystitis increased as a function of bladder dose ranging from 3% for patients receiving less than or equal to 5000 cGy to the bladder to 12% for patients receiving greater than or equal to 8001 cGy to the bladder. A similar correlation was also found for rectal dose and proctitis. The mean rectal dose for the group of patients with proctitis was higher, 6907 +/- 981 cGy, than that for the patients without proctitis, 6381 +/- 1290 cGy, p = .003. The risk of proctitis increased as a function of rectal dose ranging from 2% for patients receiving less than or equal to 5000 cGy to the rectum to 18% for patients receiving greater than or equal to 8001 cGy to the rectum. A study of the severity of the cystitis as a function of bladder dose revealed a relationship between bladder dose and the severity of the complication (Grade I cystitis = 6600 +/- 1318 cGy vs Grade III cystitis = 6856 +/- 853 cGy). A dose-response relationship was found between the rectal dose and the severity of the complication (Grade I proctitis = 6810 +/- 906 cGy vs Grade III proctitis = 6997 +/- 1137 cGy). This relationship was statistically significant, p = .003. While there was no difference in the frequency of cystitis as a function of dose to the whole pelvis, the risk of proctitis did increase with increasing doses of external beam to the whole pelvis. It ranged from 3% for patients who received 2000 cGy or less to the whole pelvis to 14% for patients who received greater than 4000 cGy to the whole pelvis, p = .02.

Entities:  

Mesh:

Year:  1989        PMID: 2912959     DOI: 10.1016/0360-3016(89)90015-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].

Authors:  H T Eich; U Haverkamp; O Micke; F J Prott; R Pötter
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

Review 2.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

3.  Radiation-associated ischemic coloproctitis: report of two cases.

Authors:  H Tomori; T Yasuda; M Shiraishi; T Isa; Y Muto; H Egawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy.

Authors:  Jihoon Lim; Blythe Durbin-Johnson; Richard Valicenti; Matthew Mathai; Robin L Stern; Jyoti Mayadev
Journal:  Int J Gynecol Cancer       Date:  2013-07       Impact factor: 3.437

Review 5.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

6.  Ureteral decompression in advanced nonurologic malignancies.

Authors:  S M Donat; P Russo
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

7.  Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy.

Authors:  Alexandra J Stewart; Robert A Cormack; Hang Lee; Li Xiong; Jorgen L Hansen; Desmond A O'Farrell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

8.  Rectal dosimetry in intracavitary brachytherapy by HDR at rural center of Maharashtra: Comparison of two methods.

Authors:  Rajeev Shrivastava; Rahul B Umbarkar; M B Sarje; K K Singh
Journal:  J Med Phys       Date:  2009-04

9.  Reproducibility of vaginal immobilization balloons in situ overnight for cervical cancer brachytherapy.

Authors:  Uma D Goyal; Paras P Mehta; Susan Samreth; John Gloss; Haiyan Cui; Denise Roe; Shona Dougherty
Journal:  J Contemp Brachytherapy       Date:  2021-05-13

10.  Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer.

Authors:  Niladri B Patra; Kazi S Manir; Swapnendu Basu; Jyotirup Goswami; Apurba K Kabasi; Shyamal K Sarkar
Journal:  J Contemp Brachytherapy       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.